FDA Investigator: Christopher R. Czajka

- Christopher R. Czajka first started conducting FDA inspections in 2010, with the last inspection in 2024. Over that time, Christopher R. Czajka has conducted 145 inspections at 136 companies across 141 sites.

Get Christopher Czajka's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Jubilant HollisterStier LLC, Spokane | 2024

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 Taenaka Kogyo Co., Ltd., Mobara | 2024

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 Chugai Pharma Manufacturing Co. Ltd., Utsunomiya | 2024

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 LGM Pharma Solutions LLC, Irvine | 2024

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 Med-Pharmex, Inc., Pomona | 2023

Out-of-stock
Christopher R. Czajka
Animal Drugs & Feeds Form 483

FDA 483 Swabplus, L.P., Rancho Cucamonga | 2023

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 TOYO Pharmaceutical Co., Ltd., Osaka | 2023

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 Toray Research Center, Inc. Nagoya Laboratory, Nagoya | 2023

Out-of-stock
Christopher R. Czajka
Human Drugs Form 483

FDA 483 Bayer Healthcare, LLC, Berkeley | 2022

Out-of-stock
Christopher R. Czajka
Human Drug Form 483

FDA 483 Partner Therapeutics Inc, Lynnwood | 2022

Out-of-stock
Christopher R. Czajka
Human Drug Form 483

FDA 483 SEAGEN INC., Bothell | 2022

Out-of-stock
Christopher R. Czajka
Human Drug Form 483

Co-Investigators (71)